Recital 14, Regulation (EU) 2022/2340

In force

The Authority recommended, in its 14 March 2018 opinion, that labelling of green tea products, with particular reference to food supplements, should include the content of (-)-epigallocatechin-3-gallate. It is important to ensure effectively and verifiably that consumers cannot be exposed to levels of (-)-epigallocatechin-3-gallate from green tea extracts that the Authority considers harmful for human health. It is therefore necessary to provide for appropriate labelling requirement indicating the content of (-)-epigallocatechin-3-gallate per portion of the food.